NPI: 1487617817 · MARYSVILLE, CA 95901 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,872 | $733K |
| 2019 | 15,347 | $1.23M |
| 2020 | 11,842 | $945K |
| 2021 | 6,723 | $685K |
| 2022 | 8,183 | $649K |
| 2023 | 9,161 | $601K |
| 2024 | 457 | $808K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,603 | 3,206 | $5.24M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 279 | 273 | $245K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,712 | 658 | $79K |
| A4657 | Syringe, with or without needle, each | 2,330 | 726 | $34K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,233 | 385 | $32K |
| 0250 | 1,633 | 121 | $14K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,642 | 765 | $7K |
| 90674 | 80 | 79 | $362.22 | |
| G0008 | Administration of influenza virus vaccine | 138 | 137 | $176.95 |
| 83550 | 53 | 49 | $0.00 | |
| 82728 | 165 | 158 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 84 | 69 | $0.00 |
| 83970 | 314 | 300 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 239 | 150 | $0.00 |
| 83540 | 180 | 168 | $0.00 | |
| 85041 | 452 | 420 | $0.00 | |
| 85048 | 422 | 391 | $0.00 | |
| 82108 | 26 | 26 | $0.00 |